Dunad Therapeutics Appoints Michael Bonney as Chair of Board of Directors
January 10, 2023
Bonney brings over 30 years of life sciences industry leadership experience as company advances its covalent chemistry platform for targeted protein degradation and beyond CAMBRIDGE,